Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RETINOL vs RIBOCICLIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RETINOL vs RIBOCICLIB: Safety Overview

Metric RETINOL RIBOCICLIB
Total FAERS Reports 296 27,997
Deaths Reported 58 4,501
Death Rate 19.6% 16.1%
Hospitalizations 198 6,700
Average Patient Age 56.3 yrs 60.2 yrs
% Female Patients 91.8% 99.0%
FDA Approval Date N/A Mar 13, 2017
Manufacturer HYDRASPHERE PLUS LLC Novartis Pharmaceuticals Corporation
Route CUTANEOUS ORAL
Marketing Status N/A Prescription